Is extraluminal fluid (EFLUID) at endoscopic ultrasonography (EUS) an accurate marker of peritoneal carcinomatosis (PC)? A prospective study

Marcia Canto, G. Gislason

Research output: Contribution to journalArticle

Abstract

Intro: In a few small retrospective series, detection of ascites by EUS is highly associated with PC in patients (pts) with gastric and pancreatic cancer. Aims: 1) To prospectively determine the prevalence of and associated risk factors for EFLUID. 2) To compare the accuracy of EUS and CT scan for the diagnosis of PC. Methods: In a prospective study, a single expert endosonographer noted the presence of any EFLUID in all EUS procedures performed over 12 months at an academic tertiary referral center. Patients with history of liver cirrhosis or advanced congestive heart failure were excluded. A final diagnosis of PC was made if peritoneal and/or omental implants and/or malignant ascites was proven by surgery or cytology. EUS and CT results were compared with final diagnoses. Bivariate analysis and multiple logistic regression were performed. Results: Of the 322 patients studied, 25 had EFLUID. It was present in 22 (13.5%) pts with malignant (n=163) and 3 (1.9%) pts with benign conditions (n = 155) (p

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume47
Issue number4
StatePublished - 1998

Fingerprint

Endosonography
Prospective Studies
Carcinoma
Ascites
Pancreatic Neoplasms
Tertiary Care Centers
Liver Cirrhosis
Stomach Neoplasms
Cell Biology
Heart Failure
Logistic Models

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{aed7949e99e746feb2c08cd3fb5997e3,
title = "Is extraluminal fluid (EFLUID) at endoscopic ultrasonography (EUS) an accurate marker of peritoneal carcinomatosis (PC)?: A prospective study",
abstract = "Intro: In a few small retrospective series, detection of ascites by EUS is highly associated with PC in patients (pts) with gastric and pancreatic cancer. Aims: 1) To prospectively determine the prevalence of and associated risk factors for EFLUID. 2) To compare the accuracy of EUS and CT scan for the diagnosis of PC. Methods: In a prospective study, a single expert endosonographer noted the presence of any EFLUID in all EUS procedures performed over 12 months at an academic tertiary referral center. Patients with history of liver cirrhosis or advanced congestive heart failure were excluded. A final diagnosis of PC was made if peritoneal and/or omental implants and/or malignant ascites was proven by surgery or cytology. EUS and CT results were compared with final diagnoses. Bivariate analysis and multiple logistic regression were performed. Results: Of the 322 patients studied, 25 had EFLUID. It was present in 22 (13.5{\%}) pts with malignant (n=163) and 3 (1.9{\%}) pts with benign conditions (n = 155) (p",
author = "Marcia Canto and G. Gislason",
year = "1998",
language = "English (US)",
volume = "47",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Is extraluminal fluid (EFLUID) at endoscopic ultrasonography (EUS) an accurate marker of peritoneal carcinomatosis (PC)?

T2 - A prospective study

AU - Canto, Marcia

AU - Gislason, G.

PY - 1998

Y1 - 1998

N2 - Intro: In a few small retrospective series, detection of ascites by EUS is highly associated with PC in patients (pts) with gastric and pancreatic cancer. Aims: 1) To prospectively determine the prevalence of and associated risk factors for EFLUID. 2) To compare the accuracy of EUS and CT scan for the diagnosis of PC. Methods: In a prospective study, a single expert endosonographer noted the presence of any EFLUID in all EUS procedures performed over 12 months at an academic tertiary referral center. Patients with history of liver cirrhosis or advanced congestive heart failure were excluded. A final diagnosis of PC was made if peritoneal and/or omental implants and/or malignant ascites was proven by surgery or cytology. EUS and CT results were compared with final diagnoses. Bivariate analysis and multiple logistic regression were performed. Results: Of the 322 patients studied, 25 had EFLUID. It was present in 22 (13.5%) pts with malignant (n=163) and 3 (1.9%) pts with benign conditions (n = 155) (p

AB - Intro: In a few small retrospective series, detection of ascites by EUS is highly associated with PC in patients (pts) with gastric and pancreatic cancer. Aims: 1) To prospectively determine the prevalence of and associated risk factors for EFLUID. 2) To compare the accuracy of EUS and CT scan for the diagnosis of PC. Methods: In a prospective study, a single expert endosonographer noted the presence of any EFLUID in all EUS procedures performed over 12 months at an academic tertiary referral center. Patients with history of liver cirrhosis or advanced congestive heart failure were excluded. A final diagnosis of PC was made if peritoneal and/or omental implants and/or malignant ascites was proven by surgery or cytology. EUS and CT results were compared with final diagnoses. Bivariate analysis and multiple logistic regression were performed. Results: Of the 322 patients studied, 25 had EFLUID. It was present in 22 (13.5%) pts with malignant (n=163) and 3 (1.9%) pts with benign conditions (n = 155) (p

UR - http://www.scopus.com/inward/record.url?scp=0345678903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345678903&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0345678903

VL - 47

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -